Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 281,652 | 270,885 | 288,592 | 292,287 | 264,472 |
| Cost of Goods | 187,361 | 180,385 | 187,828 | 193,082 | 170,727 |
| Gross Profit | 94,291 | 90,500 | 100,764 | 99,205 | 93,745 |
| Operating Expenses | 459,811 | 84,417 | 71,607 | 69,093 | 59,861 |
| Operating Income | -365,159 | 6,468 | 29,985 | 30,194 | 34,611 |
| Interest Expense | 9,526 | 12,641 | 7,104 | 6,008 | 5,526 |
| Other Income | 1,702 | -1,405 | -477 | -111 | -280 |
| Pre-tax Income | -372,983 | -7,578 | 22,404 | 24,075 | 28,805 |
| Income Tax | -30,554 | 16,670 | 7,170 | 6,737 | 9,666 |
| Net Income Continuous | -342,429 | -24,248 | 15,234 | 17,338 | 19,139 |
| Net Income Discontinuous | -5,549 | -986 | -1,139 | -338 | -2,052 |
| Minority Interests | -4,414 | -293 | -359 | -382 | -482 |
| Net Income | $-343,564 | $-24,941 | $14,454 | $17,382 | $17,569 |
| EPS Basic Total Ops | -5.47 | -0.40 | 0.22 | 0.27 | 0.26 |
| EPS Basic Continuous Ops | -5.38 | -0.38 | 0.24 | 0.27 | 0.32 |
| EPS Basic Discontinuous Ops | -0.08 | -0.02 | -0.02 | -0.01 | -0.03 |
| EPS Diluted Total Ops | -5.46 | -0.40 | 0.22 | 0.26 | 0.27 |
| EPS Diluted Continuous Ops | -5.38 | -0.38 | 0.24 | 0.27 | 0.31 |
| EPS Diluted Discontinuous Ops | -0.08 | -0.02 | -0.02 | -0.01 | -0.03 |
| EBITDA(a) | $-32,381 | $38,504 | $60,017 | $53,774 | $68,663 |